Kittens in SEC filings? Pfizer pegs Zoetis IPO at $22 to $25 per share
Pfizer filed a notice with the Securities and Exchange Commission estimating that its spinoff of its animal drug business called Zoetis will fetch $22 to $25 per share in the initial public offering.
Tags:
Kittens in SEC filings? Pfizer pegs Zoetis IPO at $22 to $25 per share,
Pfizer Latest News